Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in Cardiovascular Disease-Related Mortality in Texas.
Usman MS, Jamil A, Chunawala Z, Alam M, Nambi V, Abushamat LA, Misra A, Virani SS, Ballantyne CM, Taffet GE, Nasir K, Goel S, Al-Kindi S, Butler J, Minhas AMK. Usman MS, et al. Tex Heart Inst J. 2024 Dec 19;51(2):e248426. doi: 10.14503/THIJ-24-8426. eCollection 2024 Jul-Dec. Tex Heart Inst J. 2024. PMID: 39703786 Free PMC article.
Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis.
Patel KV, Segar MW, Klonoff DC, Khan MS, Usman MS, Lam CSP, Verma S, DeFilippis AP, Nasir K, Bakker SJL, Westenbrink BD, Dullaart RPF, Butler J, Vaduganathan M, Pandey A. Patel KV, et al. Among authors: usman ms. Circulation. 2024 Jan 23;149(4):293-304. doi: 10.1161/CIRCULATIONAHA.123.067530. Epub 2023 Nov 11. Circulation. 2024. PMID: 37950893
The cardiovascular effects of novel weight loss therapies.
Usman MS, Davies M, Hall ME, Verma S, Anker SD, Rosenstock J, Butler J. Usman MS, et al. Eur Heart J. 2023 Dec 21;44(48):5036-5048. doi: 10.1093/eurheartj/ehad664. Eur Heart J. 2023. PMID: 37966486 Review.
Association of diabetes-specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study.
Chunawala ZS, Keshvani N, Segar MW, Patel KV, Usman MS, Subramanian V, Raygor V, Chandra A, Khan MS, Pandey A. Chunawala ZS, et al. Among authors: usman ms. Eur J Heart Fail. 2024 Mar;26(3):699-701. doi: 10.1002/ejhf.3176. Epub 2024 Mar 4. Eur J Heart Fail. 2024. PMID: 38439567 No abstract available.
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis.
Usman MS, Bhatt DL, Hameed I, Anker SD, Cheng AYY, Hernandez AF, Jones WS, Khan MS, Petrie MC, Udell JA, Friede T, Butler J. Usman MS, et al. Lancet Diabetes Endocrinol. 2024 Jul;12(7):447-461. doi: 10.1016/S2213-8587(24)00102-5. Epub 2024 May 17. Lancet Diabetes Endocrinol. 2024. PMID: 38768620
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
Usman MS, Siddiqi TJ, Anker SD, Bakris GL, Bhatt DL, Filippatos G, Fonarow GC, Greene SJ, Januzzi JL Jr, Khan MS, Kosiborod MN, McGuire DK, Piña IL, Rosenstock J, Vaduganathan M, Verma S, Zieroth S, Butler J. Usman MS, et al. J Am Coll Cardiol. 2023 Jun 27;81(25):2377-2387. doi: 10.1016/j.jacc.2023.04.034. J Am Coll Cardiol. 2023. PMID: 37344038 Free article.
133 results